Verastem’s KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC, Trial City

IndustryClinical Trials ArenaOct 15, 2026

Also covered by: Clinical Trials Arena

Trial results

Read at Clinical Trials Arena

How does this affect your work day to day?

No comments yet.

Join the discussion